Anxo
Fernández Ferreiro
Publications by the researcher in collaboration with Anxo Fernández Ferreiro (45)
2024
-
Biodistribution and pharmacokinetics of [89Zr]-anti-VEGF mAbs using PET in glioblastoma rat models
International Journal of Pharmaceutics, Vol. 652
-
Preclinical characterization of endotoxin-induced uveitis models using OCT, PET/CT and proteomics
International Journal of Pharmaceutics, Vol. 662
-
Role of CYP2D6 and CYP3A4 polymorphisms on aripiprazole and dehydroaripiprazole concentrations in patients undergoing long-acting treatment
Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 135
-
The Effect of Systemic Parameters and Baseline Characteristics in Short-Term Response Analysis with Intravitreal Ranibizumab in Treatment-Naive Patients with Neovascular Age-Related Macular Degeneration
Pharmaceutics, Vol. 16, Núm. 1
-
Towards precision medicine of long-acting aripiprazole through population pharmacokinetic modelling
Psychiatry Research, Vol. 333
2023
-
Design and biopharmaceutical preclinical characterisation of a new thermosensitive hydrogel for the removal of gastric polyps
International Journal of Pharmaceutics, Vol. 635, pp. 122706
-
Efficacy and Safety of Inhaled Ethanol in Early-Stage SARS-CoV-2 Infection in Older Adults: A Phase II Randomized Clinical Trial
Pharmaceutics, Vol. 15, Núm. 2
2022
-
Cysteamine Eye Drops in Hyaluronic Acid Packaged in Innovative Single-Dose Systems: Stability and Ocular Biopermanence
Pharmaceutics, Vol. 14, Núm. 10
-
PET study of intravitreal adalimumab pharmacokinetics in a uveitis rat model
International Journal of Pharmaceutics, Vol. 627
2021
-
Anti-inflammatory effect of tacrolimus/hydroxypropyl-β-cyclodextrin eye drops in an endotoxin-induced uveitis model
Pharmaceutics, Vol. 13, Núm. 10
-
Development and characterization of a tacrolimus/ hydroxypropyl-β-cyclodextrin eye drop
Pharmaceutics, Vol. 13, Núm. 2, pp. 1-27
-
Development and characterization of inhaled ethanol as a novel pharmacological strategy currently evaluated in a phase ii clinical trial for early-stage sars-cov-2 infection
Pharmaceutics, Vol. 13, Núm. 3
-
Feasibility of Longitudinal Brain PET with Real-Time Arterial Input Function in Rats
Molecular Imaging and Biology, Vol. 23, Núm. 3, pp. 350-360
-
In situ forming and mucoadhesive ophthalmic voriconazole/HPβCD hydrogels for the treatment of fungal keratitis
International Journal of Pharmaceutics, Vol. 597
-
Review of pharmacokinetics and pharmacogenetics in atypical long-acting injectable antipsychotics
Pharmaceutics, Vol. 13, Núm. 7
2020
-
-FMISO PET/MRI Imaging Shows Ischemic Tissue around Hematoma in Intracerebral Hemorrhage
Molecular Pharmaceutics, Vol. 17, Núm. 12, pp. 4667-4675
-
3D printed tacrolimus rectal formulations ameliorate colitis in an experimental animal model of inflammatory bowel disease
Biomedicines, Vol. 8, Núm. 12, pp. 1-19
-
A multicentre prospective study evaluating the impact of proton-pump inhibitors omeprazole and pantoprazole on voriconazole plasma concentrations
British Journal of Clinical Pharmacology, Vol. 86, Núm. 8, pp. 1661-1666
-
Anti-VEGF treatment and response in age-related macular degeneration: Disease’s susceptibility, pharmacogenetics and pharmacokinetics
Current Medicinal Chemistry, Vol. 27, Núm. 4, pp. 549-569
-
Características clínicas, manejo y resultados de los pacientes con endoftalmitis estéril asociados con la inyección intravítrea de factores de crecimiento endotelial antivascular
Archivos de la Sociedad Española de Oftalmologia, Vol. 95, Núm. 5, pp. 211-216